Monday, November 16th, 2026

South Korea approves remdesivir for virus patients



SEOUL: South Korea on Wednesday issued an emergency authorization for the anti-viral drug remdesivir to be used to treat coronavirus patients, paving the way for imports.

The US authorized the emergency use of remdesivir in hospitals at the start of May, followed by Japan, while Europe has been considering following suit.

A South Korean government review of remdesivir research said it had proven “clinically meaningful” in cutting patients’ recovery times, the food and drug safety ministry said.

It will work with manufacturer Gilead Sciences to expedite the first shipment of imports, it added, without offering further details of pricing or quantities.

South Korea endured one of the worst early outbreaks of COVID-19 outside China but brought it under control with a widespread “trace, test and treat” program, with citizens largely following government safety guidelines such as wearing face masks.

It has so far reported 11,590 confirmed cases and 273 deaths from the outbreak. More than 800 patients are still under treatment or observation.

A study on over 1,000 patients in 10 countries by the US’ Institute of Allergy and Infectious Diseases found that remdesivir, injected intravenously daily for 10 days, accelerated the recovery of hospitalized patients compared to a placebo.

(With inputs from agencies)

Publish Date : 03 June 2020 20:35 PM

25 injured in bus accident in Nawalpur

NAWALPUR: At least 25 passengers were injured when a passenger

IFRC chief Chapagain urges stronger link between early warnings and disaster preparedness

KATHMANDU: Jagan Chapagain, Secretary-General of the International Federation of Red

The Truth Behind China’s 5.2% Jobless Rate

China projects the image of a rising superpower racing toward

Revisiting Last Week: Nepal’s Climate Push and Politics

KATHMANDU: The past week offered a revealing picture of Nepal’s